{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:21:54Z","timestamp":1767651714493},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.pbb.2009.07.018","type":"journal-article","created":{"date-parts":[[2009,8,9]],"date-time":"2009-08-09T08:09:55Z","timestamp":1249805395000},"page":"219-226","source":"Crossref","is-referenced-by-count":24,"title":["Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats"],"prefix":"10.1016","volume":"94","author":[{"given":"Amit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Dhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2009.07.018_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2007.10.008","article-title":"Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism","volume":"78","author":"Akula","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pbb.2009.07.018_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pbb.2009.07.018_bib3","first-page":"167","article-title":"The effect of oral administration of L-tyrosine, floic acid and pyridoxine on perphenazine-induced catatonia in rat","volume":"2","author":"Arzi","year":"2003","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.pbb.2009.07.018_bib4","first-page":"111","article-title":"New aspects of neuroprotective effects of nonsteroidal anti-inflammatory drugs","volume":"23","author":"Asanuma","year":"2003","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"10.1016\/j.pbb.2009.07.018_bib5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","article-title":"Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice","volume":"71","author":"Aubin","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2009.07.018_bib6","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/mds.21552","article-title":"Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET","volume":"22","author":"Bartels","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.pbb.2009.07.018_bib7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1172\/JCI113498","article-title":"Ischemic acute renal failure and antioxidant therapy in the rat. The relation between glomerular and tubular dysfunction","volume":"81","author":"Bird","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pbb.2009.07.018_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000108110","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"28","author":"Bornebroek","year":"2007","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.pbb.2009.07.018_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","article-title":"Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease","volume":"1362","author":"Cassarino","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pbb.2009.07.018_bib10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson's disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pbb.2009.07.018_bib11","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","article-title":"The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents","volume":"249","author":"Cohen","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2009.07.018_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/13556210500352964","article-title":"Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes","volume":"10","author":"Dhir","year":"2005","journal-title":"Addict Biol"},{"key":"10.1016\/j.pbb.2009.07.018_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.seizure.2007.05.016","article-title":"Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice","volume":"16","author":"Dhir","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.pbb.2009.07.018_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pbb.2009.07.018_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","article-title":"Non-steroidal anti-inflammatory drugs in Parkinson's disease","volume":"205","author":"Esposito","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2009.07.018_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jocn.2007.02.095","article-title":"Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study","volume":"15","author":"Etminan","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"Suppl 4","key":"10.1016\/j.pbb.2009.07.018_bib17","doi-asserted-by":"crossref","first-page":"IV37","DOI":"10.1007\/s00415-005-4008-5","article-title":"Does levodopa slow or hasten the rate of progression of Parkinson's disease?","volume":"252","author":"Fahn","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.pbb.2009.07.018_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(98)00696-7","article-title":"Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo","volume":"360","author":"Ferger","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.07.018_bib19","first-page":"239","article-title":"Nitric oxide in the pathogenesis of Parkinson's disease","volume":"80","author":"Gerlach","year":"1999","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pbb.2009.07.018_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-510X(98)00095-1","article-title":"Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases","volume":"158","author":"Gu","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pbb.2009.07.018_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","article-title":"Enzymatic oxidation of dopamine: the role of prostaglandin H synthase","volume":"64","author":"Hastings","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2009.07.018_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/01.wnl.0000204446.82823.28","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease","volume":"66","author":"Hernan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2009.07.018_bib23","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2009.07.018_bib24","first-page":"14","article-title":"Effects of some beta-adrenoceptor antagonists on oxotremorine induced tremor: physostigmine induced lethality and perphenazine induced catatonia","volume":"1","author":"Khanna","year":"1975","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.pbb.2009.07.018_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pbb.2009.07.018_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","article-title":"Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase","volume":"186","author":"Kono","year":"1978","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pbb.2009.07.018_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1254\/jjp.30.129","article-title":"Modification of drug-induced catatonia and tremors by quapazine in rats and mice","volume":"30","author":"Kulkarni","year":"1980","journal-title":"Jpn J Pharmacol"},{"issue":"Pt 3","key":"10.1016\/j.pbb.2009.07.018_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1042\/bj3140877","article-title":"Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose","volume":"314","author":"Lizasoain","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.pbb.2009.07.018_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2009.07.018_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033368","article-title":"Antipsychotic-induced oxidative stress in rat brain","volume":"13","author":"Martins","year":"2008","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pbb.2009.07.018_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pbb.2009.07.018_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00002512-199609030-00003","article-title":"New directions in the drug treatment of Parkinson's disease","volume":"9","author":"Montastruc","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pbb.2009.07.018_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease","volume":"6","author":"Mosley","year":"2006","journal-title":"Clin Neurosci Res"},{"key":"10.1016\/j.pbb.2009.07.018_bib34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0278-5846(01)00289-5","article-title":"Differential effects of cyclooxygenase inhibitors on haloperidol-induced catalepsy","volume":"26","author":"Naidu","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2009.07.018_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s007020070076","article-title":"The dopamine D2 receptor agonist alpha-dihydroergocryptine modulates voltage-gated sodium channels in the rat caudate-putamen","volume":"107","author":"Neusch","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2009.07.018_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pbb.2009.07.018_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jnr.20599","article-title":"Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease","volume":"81","author":"Okuno","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pbb.2009.07.018_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0270(85)90026-3","article-title":"Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight","volume":"13","author":"Paxinos","year":"1985","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pbb.2009.07.018_bib39","doi-asserted-by":"crossref","first-page":"30D","DOI":"10.1016\/j.amjcard.2008.02.005","article-title":"The role of leukocyte-generated oxidants in left ventricular remodeling","volume":"101","author":"Penn","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pbb.2009.07.018_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pbb.2004.05.018","article-title":"Haloperidol- and clozapine-induced oxidative stress in the rat brain","volume":"78","author":"Polydoro","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.07.018_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-2999(00)00196-5","article-title":"Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice","volume":"395","author":"Raghavendra","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.07.018_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.07.018_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1460-9568.2008.06314.x","article-title":"EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress","volume":"28","author":"Rojas","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2009.07.018_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-1-6","article-title":"Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease","volume":"1","author":"Sanchez-Pernaute","year":"2004","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pbb.2009.07.018_bib45","first-page":"882","article-title":"Role of adenosine in drug-induced catatonia","volume":"40","author":"Singh","year":"2002","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.pbb.2009.07.018_bib46","first-page":"1264","article-title":"FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats","volume":"41","author":"Singh","year":"2003","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.pbb.2009.07.018_bib47","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1016\/S0021-9258(17)36277-4","article-title":"Hydroxyl radical attack on dopamine","volume":"260","author":"Slivka","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2009.07.018_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pbb.2009.07.018_bib49","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/archneur.1975.00490500080010","article-title":"Treatment of \u201con\u2013off effect\u201d with a dopa decarboxylase inhibitor","volume":"32","author":"Sweet","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pbb.2009.07.018_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2009.07.018_bib51","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2009.07.018_bib52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pbb.2009.07.018_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-007-9080-3","article-title":"Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease","volume":"23","author":"Watanabe","year":"2008","journal-title":"Metab Brain Dis"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305709002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305709002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T13:42:19Z","timestamp":1633786939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305709002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0091305709002433"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2009.07.018","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}